Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu Disease, affects approximately one in 5,000 people. It is a rare genetic, autosomal, dominant blood vessel disorder that can cause serious and life-threatening consequences. According to the Scientific Advisory Board of the HHT Foundations International, Inc., there are four diagnostic criteria for Osler-Weber-Rendu Disease. When there are at least three of the four criteria present, there is a definite diagnosis of Osler-Weber-Rendu Disease; if two criteria are present, patients are given a possible or suspected diagnosis, and if fewer than two criteria are present, patients are said to be unlikely to have the disease.
At the Vascular Birthmark Institute of New York, we offer a multidisciplinary approach to patient care. Because Osler-Weber-Rendu Disease is a very involved and far-reaching condition, our team of specialists work together to provide our patients with the highest standard in care and treatment. Osler-Weber-Rendu Disease can cause excessive bleeding, leading to life-threatening situations. When there is skin involvement with this disease, the lesions are referred to as telangiectasias.
Telangiectasias most often occur on the face, chest, and hands, and they are known to increase in number as people age. When lesions are attached to the skin, any time injury occurs, such as a cut or a bruise, internal and external bleeding can ensue and cause excessive bleeding. Ongoing treatment must be provided for patients with Osler-Weber-Rendu Disease because of the life-threatening circumstances that can arise.
At the Vascular Birthmark Institute of New York our team of specialists will help you get the personalized treatment that you deserve to reduce not only the appearance of your lesions but also the possibility of fatal consequences. Our state-of-the-art facility and advanced technology provide patients with long-term solutions to Osler-Weber-Rendu Disease. Please contact our office today.